iShares Biotechnology ETF
IBB SectorUpdated: Apr 6, 2026, 12:07 UTC
$169.43
-0.41% today
52W: $107.43 – $179.64
52W Low: $107.43
Position: 85.9%
52W High: $179.64
Key Metrics
Expense Ratio (TER)
0.44%
Annual total expense ratio
Assets Under Management
$8.8B
Total managed assets
Dividend Yield
0.22%
Annual distribution yield
YTD Return
+0.33%
Year-to-date performance
3-Year Return (ann.)
+9.77%
Average annual (3 years)
5-Year Return (ann.)
+2.53%
Average annual (5 years)
Top 10 Holdings
| Holding | Ticker | Weight | Bar |
|---|---|---|---|
| Gilead Sciences Inc | GILD | 9.4% | |
| Vertex Pharmaceuticals Inc | VRTX | 9.1% | |
| Amgen Inc | AMGN | 8.92% | |
| Regeneron Pharmaceuticals Inc | REGN | 6.71% | |
| Alnylam Pharmaceuticals Inc | ALNY | 3.66% | |
| Insmed Inc | INSM | 2.66% | |
| argenx SE ADR | ARGX | 2.63% | |
| Biogen Inc | BIIB | 2.38% | |
| Natera Inc | NTRA | 2.32% | |
| BeOne Medicines Ltd ADR | ONC | 1.94% |
Sector Allocation
Healthcare
100%
About This ETF
The iShares Biotechnology ETF (IBB) is a Sector ETF with an expense ratio (TER) of 0.44% and $8.8B in assets under management., with its largest holdings being Gilead Sciences Inc, Vertex Pharmaceuticals Inc, Amgen Inc. The ETF currently yields 0.22% in dividends. Year-to-date, IBB has returned +0.33%.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Category: Sector
Exchange: NGM
Currency: USD
Where can I buy IBB?
Compare the best brokers for ETF savings plans — low fees, trusted providers, fully regulated.